Cost-effectiveness of Tolvaptan for Euvolemic or Hypervolemic Hyponatremia

This cost-effectiveness analysis found that the use of tolvaptan was less expensive and more effective than treatment without tolvaptan in patients with euvolemic or hypervolemic hyponatremia.